Gerben ZijlstraGlobal Technology Consultant, Continuous & Intensified Biomanufacturing at Sartorius Stedim Biotech
Gerben is a regular speaker on process intensification, process integration and continuous biomanufacturing.He received his Ph.D. from the University of Wageningen (The Netherlands) in the field of process integration in animal cell culture. He has worked for more than 20 years at CMO DSM Biologics and has been involved in the development of several commercial Bio-therapeutics, as well as innovation projects. He was one of the early adopters of Single Use bioreactors and is the first inventor of the Concentrated Fed-Batch - XD® technology, amongst others licensed by Amgen. Gerben was deeply involved in the scale-up and tech transfer of XD® technology to the Brisbane (Australia) site, which later received the 2014 ISPE facility of the year award for process innovations.Subsequently, as a Consultant at Xendo, Gerben has been working on several Continuous BioManufacturing as well as Gene Therapy projects. Since end of 2016 he has joined the Sartorius Stedim Biotech Marketing Team, where he currently holds a position as Global Technology Consultant for Intensified and Continuous BioManufacturing.